See up to 3 months of BNTX. The 7-day demo opens the 1M and 3M ranges and puts BNTX on your watchlist.
Start 7-day demoLatest BNTX insider trades
Ugur Sahin - OfficerOpen-market sale$2.49M- Ugur Sahin - OfficerOpen-market sale
About BioNTech SE (BNTX)
BioNTech SE is an SEC registrant, filing under CIK 0001776985, classified as biological products (no diagnostic substances). It is grouped with Health Care companies on this site.
BNTX Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 26 | 858,209 | $84.23M |
BNTX insider transactions (Form 4)
3720 Form 4 filings on record, the earliest from Apr 23, 2026, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Ugur Sahin - Officer | Open-market sale | Ordinary Shares | 27,000 | $92.31 | $2.49M | |
| Ugur Sahin - Officer | Open-market sale | Ordinary Shares | 36,209 | $95.37 | $3.45M | |
| Ugur Sahin - Officer | Open-market sale | Ordinary Shares | 24,000 | $95.86 | $2.30M | |
| Ugur Sahin - Officer | Open-market sale | Ordinary Shares | 21,000 | $96.81 | $2.03M | |
| Ugur Sahin - Officer | Open-market sale | Ordinary Shares | 72,000 | $97.23 | $7.00M | |
| Ugur Sahin - Officer | Open-market sale | Ordinary Shares | 17,000 | $97.46 | $1.66M | |
| Ugur Sahin - Officer | Open-market sale | Ordinary Shares | 17,000 | $96.72 | $1.64M | |
| Ugur Sahin - Officer | Open-market sale | Ordinary Shares | 34,000 | $98.26 | $3.34M | |
| Ugur Sahin - Officer | Open-market sale | Ordinary Shares | 32,000 | $98.12 | $3.14M | |
| Ugur Sahin - Officer | Open-market sale | Ordinary Shares | 27,000 | $98.69 | $2.66M | |
| Ugur Sahin - Officer | Open-market sale | Ordinary Shares | 34,000 | $98.47 | $3.35M | |
| Ugur Sahin - Officer | Open-market sale | Ordinary Shares | 30,000 | $99.40 | $2.98M | |
| Ugur Sahin - Officer | Open-market sale | Ordinary Shares | 39,000 | $98.99 | $3.86M | |
| Ugur Sahin - Officer | Open-market sale | Ordinary Shares | 33,000 | $97.81 | $3.23M | |
| Ugur Sahin - Officer | Open-market sale | Ordinary Shares | 46,000 | $100.72 | $4.63M | |
| Ugur Sahin - Officer | Open-market sale | Ordinary Shares | 34,000 | $98.60 | $3.35M | |
| Ugur Sahin - Officer | Open-market sale | Ordinary Shares | 30,000 | $96.22 | $2.89M | |
| Ugur Sahin - Officer | Open-market sale | Ordinary Shares | 34,000 | $96.49 | $3.28M | |
| Ugur Sahin - Officer | Open-market sale | Ordinary Shares | 15,000 | $96.09 | $1.44M | |
| Ugur Sahin - Officer | Open-market sale | Ordinary Shares | 45,000 | $96.93 | $4.36M | |
| Ugur Sahin - Officer | Open-market sale | Ordinary Shares | 41,000 | $99.45 | $4.08M | |
| Ugur Sahin - Officer | Open-market sale | Ordinary Shares | 20,500 | $96.31 | $1.97M | |
| Ugur Sahin - Officer | Open-market sale | Ordinary Shares | 37,000 | $99.20 | $3.67M | |
| Ugur Sahin - Officer | Open-market sale | Ordinary Shares | 36,000 | $97.78 | $3.52M | |
| Ugur Sahin - Officer | Open-market sale | Ordinary Shares | 45,000 | $102.85 | $4.63M | |
| Ugur Sahin - Officer | Open-market sale | Ordinary Shares | 31,500 | $103.52 | $3.26M | |
 Gomez Ramon Zapata - Officer | Grant or award | Option (right to buy) | 18,879 | $0.00 | - | |
| Gomez Ramon Zapata - Officer | Grant or award | Performance Share Unit | 15,103 | $0.00 | - | |
| James Timothy Patrick Ryan - Officer | Grant or award | Option (right to buy) | 12,586 | $0.00 | - | |
| James Timothy Patrick Ryan - Officer | Grant or award | Performance Share Unit | 10,069 | $0.00 | - | |
 Sierk Poetting - Officer | Grant or award | Option (right to buy) | 12,586 | $0.00 | - | |
| Sierk Poetting - Officer | Grant or award | Performance Share Unit | 10,069 | $0.00 | - | |
 Kylie Jimenez - Officer | Grant or award | Option (right to buy) | 10,488 | $0.00 | - | |
| Kylie Jimenez - Officer | Grant or award | Performance Share Unit | 8,391 | $0.00 | - | |
| Annemarie Hanekamp - Officer | Grant or award | Option (right to buy) | 12,586 | $0.00 | - | |
| Annemarie Hanekamp - Officer | Grant or award | Performance Share Unit | 10,069 | $0.00 | - | |
| Sierk Poetting - Officer | Open-market sale | Ordinary Shares | 50,000 | $110.56 | $5.53M |
Recent BNTX Form 144 notices of proposed sale
2An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| Medine GmbH | Officer, 10% Stockholder | 858,209 | $89.09M | View on EDGAR | |
| - | - | - | - |
BNTX insider trading FAQ
What is the latest insider trade for BNTX?
BioNTech SE (BNTX) had 14 insider filings in the last 90 days, with the most recent on 2026-10-09. The full record for BNTX runs to 20 Form 4 filings, the earliest from 2026-04-23. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying BNTX stock?
No insider purchases of BNTX were filed in the last 90 days.
How many insiders are selling BNTX stock?
26 insider sales of BNTX were filed in the last 90 days, totaling $84.23M.
Where can I see BNTX SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects BNTX Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Ugur Sahin view on EDGAR
- - Ugur Sahin view on EDGAR
- - Ugur Sahin view on EDGAR
- - Ugur Sahin view on EDGAR
- - Ugur Sahin view on EDGAR
- - Ugur Sahin view on EDGAR
- - Ugur Sahin view on EDGAR
- - Ugur Sahin view on EDGAR
- - Ugur Sahin view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where BNTX's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow BNTX with a 7-day demo
- BNTX on your watchlist
- Every BNTX Form 4 filing on record
- Up to 3 months of BNTX price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
